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	Abstract: Background: Formulations employing synergistic combinations of antibiotics with Essential Oils (EOs) could help to preserve the antibiotic repertoire by improving their activity against resistant bacteria.  Objective: This study aimed to screen the antibiotics oxacillin and ciprofloxacin for synergistic interactions with cumin, oregano and rosewood EOs and the EO components cuminaldehyde, carvacrol and linalool against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus (antibiotic sensitive and resistant isolates). This will inform the formulation of synergistic combinations of EOs and antibiotics to resensitise antibiotic resistant bacteria. Method: Antimicrobial interactions between double and triple combinations of EOs, EO components and antibiotics were determined using the checkerboard method with calculation of Fractional Inhibitory Concentration Indexes (FICIs). The most active triple combinations were then assessed by a time-kill assay. Results: Two synergistic EO-antibiotic combinations and eight additive EO-antibiotic combinations reduced the antibiotic minimum inhibitory concentration below clinical sensitivity breakpoints according to the checkerboard method. However all tested combinations were additive according to the time-kill assay; while the combinations completely killed S. aureus, E. coli and P. aeruginosa in 2 h, at least one EO compound from the combination alone completely killed the test species. Conclusion: Positive interactions support the use of EOs or EO components to enhance antibiotic efficacy against antibiotic resistant bacteria. The EO-antibiotic combinations tested by the time kill assay were indifferent; therefore, the observed antimicrobial activity did not arise from synergistic mechanisms as indicated by the checkerboard method. Investigation of other synergistic combinations identified by the checkerboard method could reveal more promising candidates. 
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1. INTRODUCTION
	The antibiotic pipeline has failed to adequately meet clinical need for new therapies to treat antibiotic resistant infections [1]. In the last two decades, only five new antibiotic classes have been brought to market: oxazolidinone, lipopeptide, pleuromutilin, tiacumicin and diarylquinoline [2], while the number of antimicrobial-resistant bacteria have increased over the same time period, reducing treatment options available for once treatable infections [3]. The development of new antimicrobials is an important facet in strategies to combat antibiotic resistance. Pathogens of high priority include Pseudomonas aeruginosa, Staphylococcus aureus and Enterobacteriaceae such as Escherichia coli due to their prevalence of resistance and 
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healthcare burden [1].	
The lack of novel antimicrobials being discovered using genomic and high throughput screening approaches has resulted in a renewed interest in natural products, which may be a source of antimicrobials with new targets and mechanisms of action [4]. Extensive research has been conducted on the antimicrobial activity of Essential Oils (EOs) and their constituent compounds; several EOs have been shown to inhibit a broad spectrum of bacterial species [5], including antibiotic resistant strains [6], indicating that they may be suitable for further investigation as antimicrobial formulations. For example, methicillin sensitive and methicillin resistant Staphylococcus aureus (MSSA and MRSA), vancomycin sensitive and vancomycin resistant Enterococcus faecium (VSE and VRE) and ciprofloxacin sensitive (CS) and ciprofloxacin resistant (CR) Escherichia coli and Pseudomonas aeruginosa were inhibited by oregano (Origanum compactum Benth), cumin (Cuminum cymimum L.) and rosewood (Aniba roseadora Ducke) EOs at Minimum Inhibitory Concentrations (MICs) ranging 0.29-37.20 mg/mL and their respective major components carvacrol, cuminaldehyde and linalool at MICs ranging 0.99-912.80 mM [7]. 
	Several studies have reported EOs to interact synergistically with conventional antibiotics, resulting in increased antibiotic sensitivity in resistant isolates [8]. Recently, colistin was reported to possess synergistic activity in combination with the EO compound eugenol against fourteen E. coli isolates (colistin-sensitive and colistin resistant), reducing the MIC of colistin by four to eight-fold [9], and a combination of cefotaxime. Thyme (Thymus vulgaris) EO was reported to synergistically inhibit extended spectrum β-lactamase producing E. coli, which reduced the MIC of cefotaxime from 32 to 8 µg/mL [10]. Formulations based on synergistic combinations of antibiotics and EOs or EO compounds that reduce the antibiotic effective dose below clinical resistance breakpoints could be employed to extend the life of current antibiotics [11]. 




	Test species used were Ciprofloxacin-Sensitive (CS) E. coli NCTC 8003, ciprofloxacin resistant (CR) E. coli (clinical isolate), CS P. aeruginosa NCTC 6749, CR P. aeruginosa (clinical isolate), MSSA NCTC 12981 and MRSA NCTC 12497. Clinical isolates were acquired from Leicester Royal Infirmary (Leicester, UK). 
2.2 Essential oils 
	A. roseadora Ducke (rosewood), C. cymimum L. (cumin) and O. compactum Benth (oregano) EOs were supplied by Penny Price Aromatherapy Ltd (Hinckley, UK). The chemical composition of the EOs were determined previously by Owen et al. [7] using gas chromatography. Cumin EO contained 17.66% cuminaldehyde, rosewood EO contained 54.75% linalool and oregano EO contained 66.61% carvacrol [7].  Carvacrol, cuminaldehyde and linalool standards were acquired from Sigma Aldrich (Gillingham, UK).  
2.3 Antibiotics
	Oxacillin sodium salt powder was obtained from Scientific Laboratory Supplies (Nottingham, UK) and ciprofloxacin and vancomycin hydrochloride powders from Fisher Scientific (Loughborough, UK). Antibiotic stock solutions were prepared in distilled water and sterilized using a 0.45 µm PTFE syringe filter (Merck Millipore, Watford, UK). Solutions were stored at -20°C for no longer than 30 days.
2.4 Antimicrobial susceptibility
	A microdilution method adapted from the International Standards Office antibiotic susceptibility test [12] was used. A two-fold dilution series of antibiotic stock solutions were prepared in nutrient broth in a 96-well plate. An equal volume of a bacterial suspension was then added to a final concentration of ~5x105 Colony Forming Units (CFU)/mL and antibiotic concentrations ranging 256-0.008 mg/L. Controls of antibiotic free and bacterial inoculum free wells were included. The MIC was calculated by measuring OD595 nm at 0 h and again after 24 hours’ incubation at 37°C using a Molecular Devices (Sunnyvale, USA) Spectramax Plus 384 microplate reader and Softmax Pro version 6.4 software. Antibiotic susceptibility was determined by comparing MICs to the European Committee of Antimicrobial Susceptibility Testing (EUCAST) clinical susceptibility breakpoints [13]. MICs of cumin, oregano and rosewood EOs and their respective major components cuminaldehyde, carvacrol and linalool were previously determined using this method [7].
2.5 Antimicrobial interactions between essential oils, their major components and antibiotics 
	The checkerboard method with calculation of Fractional Inhibitory Concentration Indexes (FICIs) was used to determine the antimicrobial relationships between double combinations of cumin, oregano and rosewood EOs, double combinations of the components carvacrol, cuminaldehyde and linalool, and double combinations of the EOs or EO components with ciprofloxacin and oxacillin. 
	Antibiotics, EOs and EO components were serially diluted in nutrient broth (Oxoid, Basingstoke, UK) containing 10% (v/v) Dimethyl Sulfoxide (DMSO; Fisher Scientific, Loughborough, UK) and combined in microtitre plates so that the concentrations of one antimicrobial decreased along the columns and concentrations of the other antimicrobial decreased over the rows of the plate before being inoculated with the test organism (final well concentration 106 CFU/mL). For triple combinations, concentrations of the third agent were varied over multiple plates. The range of EO, EO component and antibiotic concentrations tested in checkerboard assays are outlined in Table 1. A control of bacteria in broth and 10% DMSO alone was included. Inhibition of bacterial growth was determined by measuring OD595 nm as described for antibiotic MICs. Interactions between the combinations were determined by calculating FICIs according to the equation:
FICI = (MICEO in combination/MICEO alone) + 
(MICantibiotic in combination/MICantibiotic alone)                                  
	Combinations with an FICI ≤ 0.5 were considered synergistic, FICIs >0.5 to 4 were considered indifferent and FICIs >4 were considered antagonistic [14]. 
2.6 Time-kill assay 
	A neutraliser comprised of tryptone sodium chloride (1 g/L tryptone (Oxoid) and 8.5 g/L sodium chloride (Fisher Scientific)) containing 30g/L saponin (Fisher Scientific), 30 g/L polysorbate 80 (Fisher Scientific), 5g/L sodium thiosulphate (Fisher Scientific) 3g/L asolectin from soyabean (Sigma Aldrich) and 1g/L L – histidine (Sigma Aldrich) was used in time-kill assays to prevent antimicrobial carryover during enumeration. 
	The neutraliser was validated as non-toxic using an adapted version of the British Standards Institute BS EN 1040 

Table 1, Concentration range of EOs, EO compounds and antibiotics studied in checkerboard assays. 
	Concentration range (Antibiotic, mg/L; EO, mg/mL; EO compound, mM)
	MSSA	MRSA	CS E. coli	CR E. coli	CS P. aeruginosa	CR P. aeruginosa


























neutraliser control validation test [15].  An aliquot of 100 µl E. coli, S. aureus or P. aeruginosa (109 CFU/mL) was added to 9.9 mL neutraliser, or 9.9 mL Phosphate Buffered Saline (PBS; Oxoid) as a control, and left in contact for 5 mins before being diluted as required in PBS and spread plated onto agar. Survivors were enumerated after 24 hrs’ incubation at 37°C. The neutraliser was considered non-toxic as the mean CFU/mL of survivors in neutraliser were greater than or equal to 0.5 times the survivors in the control [15]. 
	The neutraliser was validated as efficacious against the EO compounds, antibiotics and combinations to be investigated (Table 2) using an adapted version of the BS EN 1040 dilution-neutralization validation test [15]. Solutions of EO compounds, antibiotics and combinations to be investigated were prepared in broth supplemented with 10% DMSO and 1 mL was added to 8.9 mL neutraliser. After 5 mins, 100 µl test microorganism was added and left in contact for 1 min before dilution in PBS and plating. A viability control of 100 µl test microorganism in 9.9 mL PBS was also included. The neutraliser was deemed effective against each agent as the mean CFU/mL of survivors in test solutions were greater than or equal to 0.5 times the control [15].
	For the time kill assay, E. coli, S. aureus or P. aeruginosa (106 CFU/mL) were added to solutions of triple EO-antibiotic combinations or each agent at the concentration present in the triple combination in nutrient broth with 10% (v/v) DMSO. The triple EO-antibiotic combinations used in the time-kill assay are described in Table 2. Nutrient broth with 10% (v/v) DMSO alone was included as a control. After 0, 2, 4, 8, 12 and 24 h incubation, an aliquot of the reaction mixture was diluted 1:10 in neutralizer. After 5 mins of contact with the neutraliser, the reaction mixture was serially diluted in PBS as required and spiral plated (easySpiral®, Interscience, St Nom la Breteche, France) onto nutrient agar (Oxoid). Plates were incubated at 37°C for 24 h incubation before enumeration.







Table 2, Triple antibiotic-EO component combinations investigated using the time-kill assay.






























	MIC and FICI tests were repeated in triplicate on two occasions (n=6) except for the time kill assays, which were repeated in duplicate on two separate occasions (n=4). MICs are mode values and FICIs were calculated from mean absorbance change values. 

3. RESULTS AND DISCUSSION
	Antibiotic MICs were concordant with assumed antibiotic sensitivity of the test organisms as per EUCAST (13) breakpoints. MICs of oxacillin were 0.25 mg/L and 32 mg/L against MSSA and MRSA, respectively. MICs of ciprofloxacin were 0.063 mg/L for CS E. coli, 128 mg/L for CR E. coli, 0.125 mg/L for CS P. aeruginosa and 2 mg/L for CR P. aeruginosa. Owen et al. [7] reported that cumin, oregano and rosewood EOs possessed MICs of 0.29-37.20 mg/mL against E. coli, P. aeruginosa and S. aureus, and their components carvacrol, cuminaldehyde and linalool had MICs of 0.99-912.80 mM, indicating that they could be candidates for the investigation of antimicrobial interactions with antibiotics.
	Synergistic combinations of EOs or EO components were found against MSSA, MRSA, CS E. coli and CR P. aeruginosa (Table 3) which resulted in marked reductions in MICs, for example the MICs of carvacrol and cuminaldehyde were reduced four and thirty-two-fold, respectively in combination (FICI = 0.28). Synergistic combinations of EOs or EO components may be beneficial in novel antimicrobial formulations compared to individual EOs or EO components as decreased doses may reduce the likelihood of any adverse effects. Skin irritation and allergy is correlated with increasing concentrations of EOs [17], and several EOs and components, such as coriander EO and carvacrol, are genotoxic at high concentrations in vitro [18]. 




















































































membrane or other intracellular targets, resulting in a synergistic effect [21]. 
	Five synergistic EO component-antibiotic combinations were identified in this study, however the only combination to result in a changed resistance phenotype according to EUCAST [13] breakpoints was cuminaldehyde and ciprofloxacin against CR P. aeruginosa, which reduced ciprofloxacin’s MIC from 2 to 0.5 mg/L (Table 4). Few studies of EO-antibiotic combinations report antibiotic MIC reductions in synergistic combinations sufficient to alter the antibiotic resistance phenotype. Knezevic et al. [22] reported that eucalyptus (Eucalyptus camaldulensis) restored polymixin B sensitivity in a resistant isolate of Acinetobacter baumanii according to sensitivity breakpoints, with total  
MIC reductions of two to eight-fold. Combinations that                    result in antibiotic sensitisation according to clinical breakpoints are more likely to be of clinical importance; susceptible MICs represents a greater likelihood of positive clinical outcomes as well as the achievable antibiotic exposure by consideration of pharmacokinetics and pharmacodynamics of the drug [23]. 
	The MIC of ciprofloxacin against CR P. aeruginosa was also reduced to below the antibiotic sensitivity breakpoint [13] in an indifferent combination with carvacrol, linalool, cuminaldehyde, oregano and rosewood. This was also the case for linalool and ciprofloxacin against CR E. coli (Table 4). In these cases, the EO or EO component was largely unchanged, suggesting that these components act as adjuvants rather than synergistically. The lack of activity of these combinations against the antibiotic-sensitive isolates suggests potential antibiotic resistance modulating activity. The relatively inactive EO component (-)-α-pinene modulated resistance to ciprofloxacin and erythromycin in Campylobacter jejuni, decreasing their MICs between two and over 512-fold as a result of decreased membrane integrity, metabolic disruption and inhibition of the efflux pumps ΔcmeB and ΔCj1687 [24]. P. aeruginosa possesses at least four efflux systems confer resistant to multiple antibiotic classes, with fluoroquinolones being a substrate of all four [25] while CR E. coli overexpresses the AcrAB-TolC efflux pump [26]. The effect of the lead combinations against efflux pumps present in E. coli and P. aeruginosa could be investigated as a potential mechanism of antibiotic sensitisation. The concentration of EO components required to exert the observed affects in indifferent combinations with ciprofloxacin were relatively high (57.05 mM linalool against CR E. coli and 31.62-912.80 mM carvacrol, cuminaldehyde and linalool against CR P. aeruginosa). The use of high EO compound concentrations could result in 
problems with toxicity and so reduce the clinical utility of the combinations compared to synergistic combinations, where the effective doses of EO components would be reduced. 
	Conversely, the MIC of ciprofloxacin against CS P. aeruginosa and CS E. coli increased above the antibiotic resistance breakpoint [13] (Table 4), in combination with cuminaldehyde or oregano and rosewood EOs, respectively. These combinations are therefore unlikely to be useful in combatting antibiotic resistance. Further research could determine if expression of ciprofloxacin resistance genes is upregulated by these combinations; this may aid in the 
















































































prediction of combinations that contribute to the emergence of resistance.   
	Combining three antimicrobial agents could be a useful strategy to further reduce MICs of such agents. Gonzales et al. [27] demonstrated that a combination of meropenem, piperacillin and tazobactam had a lower FICI (0.11) and MICs (2 µg/mL each) than double combinations of these agents (FICIs = 0.44, 0.67 and 0.22; MICs = 2/4, 8/2 and 16/2 µg/mL, respectively). In this study, double combinations of EOs or components with synergistic activity (Table 3) were tested in combination with antibiotics (Table 5) as a potential strategy to further increase antibiotic susceptibility in addition to reducing the required concentration of EOs or EO compounds and thus potential toxicity. Triple combinations containing linalool were tested against CR E. coli, due to all double EO component combinations being indifferent, but a double combination of linalool and ciprofloxacin synergistically reduced the MIC of ciprofloxacin against CR E. coli to below the EUCAST [13] antibiotic resistance breakpoint. According to the checkerboard method, all combinations tested reduced the antibiotic MICs of the resistant isolates to below their antibiotic sensitivity breakpoints [13] except a combination of linalool, carvacrol and ciprofloxacin against CR E. coli (Table 5), while the MICs of EOs and EO components were reduced to a greater extent than double combinations. 
	The time-kill assay revealed that a combination of oxacillin, linalool and cuminaldehyde was indifferent against MSSA, as linalool and cuminaldehyde alone were bactericidal after 2 h contact (Figure 1). The triple combination immediately reduced MRSA to 1.43 log10 CFU/mL, whereas linalool, cuminaldehyde and oxacillin had a similar number of survivors to the control at time point 0 (3.31-3.83 log10 CFU/mL). EOs and EO compounds can be rapidly bactericidal; Zanthoxylum limonella EO (4 g/L) and its’ major component sabinene (67.6 g/L) completely killed S. aureus and E. coli within 3 to 6 mins [28], and this may account for the immediate reduction in cell numbers at 0 h of contact. However, linalool and cuminaldehyde alone completely inhibited MRSA after 2 h in a similar manner to MSSA. As synergy is defined by a 2 log10 CFU/mL reduction in the combination compared to the individual agents at the 24 h time point (16), the combination was not synergistic despite a more rapid bactericidal effect than the individual compounds. 
	A combination of ciprofloxacin, linalool and carvacrol completely killed CS E. coli and CR E. coli after 2 h (Figure 2) while carvacrol and ciprofloxacin alone failed to inhibit growth. Linalool alone completely killed CS E. coli and CR E. coli after 2 h, indicating that the ternary combination is indifferent in agreement with the checkerboard method. As such the time-kill analysis showed that one or both of the EO components were bactericidal against S. aureus and E. coli while the antibiotics were non-inhibitory, indicating that the antibiotics were superfluous and resulting in the combination not modulating antibiotic resistance. 




























































was bactericidal against CS P. aeruginosa after 2 h, whereas these agents reduced CR P. aeruginosa from 4.55 to 2.17-2.93 log10 CFU/mL at 0 h, indicating that they were rapidly antimicrobial, despite carvacrol and cuminaldehyde being present at sub-MIC concentrations (Figure 3a). Regrowth of CR P. aeruginosa treated with carvacrol to 4.21 log10 CFU/mL over 24 h was observed after an initial reduction below the 2 log10 detection limit after 2 h. Recovery of cell numbers in the time kill assay has been observed for sub-inhibitory antimicrobial concentrations but may also arise from the emergence of a resistant subpopulation, antimicrobial degradation or due to adherence of bacteria to the test container surface before being released into the test solution at a later time point [29]. Ciprofloxacin failed to inhibit CS P. aeruginosa, while CR P. aeruginosa was reduced to below the detection limit of 2 log10 CFU/mL after 4 h before re-growing. Gregoire et al. [30] also observed an initial decrease in cell numbers followed by regrowth for P. aeruginosa exposed to ciprofloxacin at its’ MIC in the time kill assay. Recovery of cell numbers in the time kill assay may have arisen from the use of a sub-inhibitory concentration of ciprofloxacin [29] and was unlikely to be caused by antibiotic degradation during incubation as ciprofloxacin is known to be stable at 37°C for greater than 24 h [30]. 
	Several studies have reported categorical disagreement between the checkerboard and time-kill methods. Foweraker et al. [31] reported that antibiotic combinations were synergistic according to the checkerboard method and indifferent by the time kill assay against two of eight P. aeruginosa isolates.  Sopirala et al. [32] also reported that nine out of fifteen antibiotic combinations were additive or indifferent against Acinetobacter baumanii according to the checkerboard method, while the time-kill method showed synergy. It is known that the checkerboard method can be subject to errors in reproducibility [33], and that the time kill assay is superior in sensitivity [34]. By increasing the number of agents within the checkerboard assay to three, it is likely that reproducibility errors further incurred are considerable, and so may have resulted in the observed false conclusions of synergy or overestimation of the bactericidal activity of the EO components. The labour-intensive nature of the time-kill assay makes it unrealistic to determine antimicrobial interactions of a large number of combinations using this method. The checkerboard method can be used as a higher throughput screening assay to process a large number of combinations, reducing the number of potential drug candidates to a smaller number for further efficacy testing via a time kill assay which should always be used to confirm positive findings.

4. CONCLUSION
	Formulations employing synergistic combinations of antibiotics with EOs or EO components may offer a potential solution to antibiotic resistance by enhancing antibiotic efficacy against resistant bacteria. Using the checkerboard method, two synergistic EO-antibiotic combinations and eight additive EO-antibiotic combinations reduced the antibiotic MIC below clinical sensitivity breakpoints, in support of the combination of antibiotics and EOs/EO compounds to preserve the activity of current antibiotics.  Further investigation of triple EO compound-antibiotic combinations using a time kill assay indicated that antibiotic resistance was not modulated, indicating that these combinations were not beneficial over the use of EOs or EO compounds alone. Discrepancies between the checkerboard method and the time kill assay highlights the need to validate antimicrobial interactions determined by the checkerboard method using other viable count screening methods. Investigation of other synergistic combinations identified by the checkerboard method could reveal more promising candidates. 
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